Literature DB >> 6413689

Histocompatibility antigens in polymyalgia rheumatica and giant cell arteritis.

R D Armstrong, A Behn, A Myles, G S Panayi, K I Welsh.   

Abstract

Fifty-five Caucasoid patients with polymyalgia rheumatica or giant cell arteritis were typed for HLA, A, B, C and DR locus antigens. In the total patient group, DR4 had a significantly increased frequency. The prevalence of CW3 and CW6 was also significantly increased, the rise of CW3 possibly being attributable to its well-documented linkage disequilibrium with DR4. The rise in CW6 cannot be attributed to its known linkage disequilibrium with DR7.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6413689

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  8 in total

1.  Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  B Dasgupta; O Duke; A M Timms; C Pitzalis; G S Panayi
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

2.  HLA antigens in polymyalgia rheumatica in northern Sweden.

Authors:  A Uddhammar; B N Sojka; S Rantapää-Dahlqvist
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

Review 3.  Revisited HLA and non-HLA genetics of Takayasu arteritis--where are we?

Authors:  Chikashi Terao
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

4.  Utility of temporal artery biopsy samples for genome-wide analysis of giant cell arteritis.

Authors:  K Cremin; P Leo; J E Harris; E De Smit; L Bradbury; P McKelvie; C L Hill; M A Brown; A W Hewitt
Journal:  Genes Immun       Date:  2014-05-15       Impact factor: 2.676

5.  Polymyalgia rheumatica/giant cell arteritis in husband and wife.

Authors:  M V Kyle; B L Hazleman; R H King
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

6.  Peripheral neuropathy associated with temporal arteritis.

Authors:  B Fishel; G Zhukovsky; M Alon; M Talesnic; J Joussiphov; Y Fintsi; M Yaron
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 7.  Epidemiology and optimal management of polymyalgia rheumatica.

Authors:  P Labbe; P Hardouin
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

8.  Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status.

Authors:  Raquel López-Mejías; Fernanda Genre; Belén Sevilla Pérez; Santos Castañeda; Norberto Ortego-Centeno; Javier Llorca; Begoña Ubilla; Sara Remuzgo-Martínez; Verónica Mijares; Trinitario Pina; Vanesa Calvo-Río; Ana Márquez; José A Miranda-Filloy; Antonio Navas Parejo; Marta Conde-Jaldón; Lourdes Ortiz-Fernández; Diego Argila; Maximiliano Aragües; Esteban Rubio; Manuel León Luque; Juan María Blanco-Madrigal; Eva Galíndez-Aguirregoikoa; Francisca González Escribano; J Gonzalo Ocejo-Vinyals; Javier Martín; Ricardo Blanco; Miguel A González-Gay
Journal:  Arthritis Res Ther       Date:  2015-04-14       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.